MedPath

Evaluation of the use of Hydroxychlorochine in Chinese flu

Phase 2
Not yet recruiting
Conditions
non specified coronavirus infection/ coronavirus
B34.2
Registration Number
RBR-3k4wxb
Lead Sponsor
Hospital Santo Antônio
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not yet recruiting
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Positive RT-PCR; age> 18 years; discrete classification (without signs of dyspnea, and oximetry greater than 93%)

Exclusion Criteria

Need for ICU on day 0; allergy to hydroxychloroquine or azithromycin; retinopathy; G6PD deficiency; QT extension; lactation; pregnancy; hepatic insufficiency; acute renal failure; patients who did not sign the informed consent

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.